Canada· CA-DIN-02552523
DAYBUE
A trofinetide product containing trofinetide, registered in Canada by ACADIA PHARMACEUTICALS INC.. The same ATC class is registered in 7 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Trofinetide is registered in 7 of 19 countries.
Countries holding a registration under ATC N07XX24 (trofinetide), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 4 of them publish a price we can compare per daily dose
Trofinetide · ATC N07XX24
7 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- TROFINETIDE
- Manufacturer
- ACADIA PHARMACEUTICALS INC.
- Country
- Canada (CA)
- ATC code
- N07XX24
- ATC class
- Trofinetide
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Trofinetide in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDaybueAcadia Pharmaceuticals Inc.
- BelgiumDaybu 200 mg/mlAcadia Pharmaceuticals (Netherlands)
- CzechiaDAYBUAcadia Pharmaceuticals (Netherlands) B.V., Amsterdam
- FinlandDaybuAcadia Pharmaceuticals (Netherlands) B.V.
- PolandDaybuAcadia Pharmaceuticals (Netherlands) B.V.
- SwedenDaybu 200 mg/ml Oral lösningAcadia Pharmaceuticals (Netherlands) B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/99e9c60e-51c8-467e-8983-832eeff7dc84 GET /v1/drugs/99e9c60e-51c8-467e-8983-832eeff7dc84?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02552523",
"form": "SOLUTION",
"class": "Human",
"routes": [
"GASTRIC",
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "N07XX24",
"schedule": [
"Prescription"
],
"drug_code": "104149",
"strengths": [
"200 MG"
],
"ahfs_class": null,
"substances": [
"TROFINETIDE"
],
"product_categorization": null
}See everything about trofinetide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.